New option with added vitamin B6 may help women who suffer from severe nausea and vomiting during their pregnancy
SAN ANTONIO, TX (March 1, 2010) – Mission Pharmacal announced today the addition of CitraNatal® B-Calm to its CitraNatal® family of prescription prenatal vitamins. CitraNatal B-Calm offers gentle prenatal nutrition plus the benefits of additional vitamin B6, which supplements a woman's own defense against severe pregnancy-related nausea and vomiting. Emerging science suggests that vitamin B6 supplementation can be beneficial for pregnant women who suffer with severe nausea during pregnancy.
"For many women, pregnancy-related nausea and vomiting can be a serious concern," said Neill Walsdorf, Jr., president of Mission Pharmacal. "We are pleased to offer women a prenatal vitamin option that may help provide some relief during their pregnancies, while providing the quality and comfort women have come to trust with the CitraNatal name."
As many as 85 percent of pregnant women may experience nausea and up to half may experience vomiting early during their pregnancies. With 75 mg of vitamin B6 dosed over 24 hours, CitraNatal B-Calm may be used in conjunction with a physician prescribed regimen to help minimize these symptoms.
CitraNatal B-Calm contains 25 mg of vitamin B6 in the multivitamin and two 25 mg vitamin B6 supplements to be taken at eight-hour intervals. Vitamin B6 is recommended by The American College of Obstetricians and Gynecologists as a safe and effective first-line supplementation for pregnancy-related nausea and vomiting. The multivitamin tablet also contains a signature CitraNatal formula with gentle ingredients for mom and strong nutrition for baby, including folic acid, calcium citrate and carbonyl iron.
In addition, Mission Pharmacal is currently working to add a recently acquired, dual-iron technology into the existing CitraNatal family of prescription prenatal vitamins, including CitraNatal B-Calm, as well as Ferralet 90, a prescription oral iron supplement for the treatment of iron deficiency anemia. The new technology is a varied release of carbonyl iron and ferrous gluconate that combines the quick uptake of a ferrous salt and the more prolonged absorption in the body of carbonyl iron.
Women who are pregnant or planning to conceive should consult their healthcare providers prior to beginning any prenatal vitamin regimen.
About the CitraNatal® Line
CitraNatal is marketed by Mission Pharmacal Company based in San Antonio, Texas. CitraNatal vitamins are specially formulated for the many women who require nutritional support prior to conception, throughout pregnancy, and during the postnatal period. The plant-derived DHA found in several CitraNatal products is produced exclusively by Martek Biosciences Corporation based in Columbia, Maryland.
About Mission Pharmacal
Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas. For more than 60 years, the company has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them. Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products. For more information, visit www.missionpharmacal.com or www.citranatal.com.
Media Contact:
Ami Shah
Cohn&Wolfe
(212) 798-9773
ami.shah@cohnwolfe.com
Important Safety Information
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Warnings
Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.
Please see full Prescribing Information
Expecting? Estimate your due date with this online pregnancy wheel.
Click here for an interactive guide to a baby's growth and development during a typical pregnancy.
More than 500,000 babies are born too soon each year. Some are so small they struggle to survive. This year, Mission Pharmacal is joining forces with the March of Dimes* as a National Corporate Sponsor to help raise awareness about the growing crisis of premature birth. To learn more and help us fight prematurity, click on the links below. For more than 60 years, Mission Pharmacal has been committed to providing products for healthy women and healthy babies.
